We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
55 hedge funds and large institutions have $166M invested in State Street SPDR S&P Pharmaceuticals ETF in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
64% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 14
7% less funds holding
Funds holding: 59 → 55 (-4)
24% less capital invested
Capital invested by funds: $218M → $166M (-$51.9M)
28.41% less ownership
Funds ownership: 92.26% → 63.85% (-28%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Holders
55
Holders Change
-4
Holders Change %
-6.78%
% of All Funds
1.78%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
6
Increased
23
Reduced
14
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PFG
Pacific Financial Group
Bellevue,
Washington
|
+$4.92M |
| 2 |
LPL Financial
San Diego,
California
|
+$3.95M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$3.6M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.57M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.97M |
